{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-028821","form_type":"8-K","ticker":"MRKR","cik":"0001094038","company_name":"Marker Therapeutics, Inc.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.912973+00:00","generated_at":"2026-05-24T03:38:18.876899+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"confidence":"high","headline":"Marker Therapeutics stockholders approve issuance of 8.28M warrant shares","bullets":["At special meeting on March 21, 2025, 4,158,543 shares (38.83% of outstanding) represented.","Proposal passed: 3,483,897 for, 668,383 against, 6,263 abstained.","Approves issuance of up to 5,031,250 shares under Series A Warrants and 3,247,445 under Series B Warrants.","Total authorized warrant shares: 8,278,695, approximately 77% of 10.7M outstanding shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-028821","json":"https://secwatch.observer/filing/0001104659-25-028821.json","markdown":"https://secwatch.observer/filing/0001104659-25-028821.md","text":"https://secwatch.observer/filing/0001104659-25-028821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/0001104659-25-028821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/tm2510592d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:38:18.876899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}